Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06835218
What this trial is testing

PROCARE - PROstate Cancer Real World Evidence Registry

Who this might be right for
Prostate CancerBiochemical Recurrence of Malignant Neoplasm of ProstateNon-metastatic Castration-resistant Prostate Cancer+2 more
UroTrials Company (GmbH) 5,000
Very early researchEnded earlyNCT06516510
What this trial is testing

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Blue Earth Therapeutics Ltd 17
Not applicableEnded earlyNCT03503097
What this trial is testing

Genetic Testing for Men With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8
University of Washington 799
Testing effectiveness (Phase 2)Study completedNCT01560923
What this trial is testing

Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Masonic Cancer Center, University of Minnesota 47
Testing effectiveness (Phase 2)Study completedNCT00005828
What this trial is testing

Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 54
Not applicableStudy completedNCT03228810
What this trial is testing

Genetic Biomarker Discovery for Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 4
Testing effectiveness (Phase 2)Study completedNCT02036060
What this trial is testing

Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.

Who this might be right for
Metastatic Prostate Cancer
Spanish Oncology Genito-Urinary Group 119
Large-scale testing (Phase 3)Looking for participantsNCT06350825
What this trial is testing

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

Who this might be right for
Metastatic Prostate CancerTherapy, Directly Observed
The First Affiliated Hospital with Nanjing Medical University 200
Large-scale testing (Phase 3)Study completedNCT02260817
What this trial is testing

Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Global Isotopes, LLC d/b/a Zevacor Molecular 109
Large-scale testing (Phase 3)Active Not RecruitingNCT04821622
What this trial is testing

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

Who this might be right for
Prostate Cancer
Pfizer 599
Testing effectiveness (Phase 2)Study completedNCT00115635
What this trial is testing

Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Herlev Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05189457
What this trial is testing

First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

Who this might be right for
Prostate CancerStage IV Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 32
Not applicableLooking for participantsNCT06981377
What this trial is testing

PRostate Cancer Plasma Integrative Multi-modal Evaluation

Who this might be right for
Metastatic Prostate Cancer
Santa Chiara Hospital 800
Testing effectiveness (Phase 2)Looking for participantsNCT06675357
What this trial is testing

Using FAPI PET/MRI to Evaluate Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic DiseaseProstate Cancers
University of Wisconsin, Madison 30
Testing effectiveness (Phase 2)Study completedNCT02278055
What this trial is testing

Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerPain
Memorial Sloan Kettering Cancer Center 29
Large-scale testing (Phase 3)Study completedNCT01020448
What this trial is testing

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Ipsen 339
Early research (Phase 1)Not Yet RecruitingNCT07756593
What this trial is testing

Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate Cancer
Washington University School of Medicine 30
Testing effectiveness (Phase 2)Looking for participantsNCT06782555
What this trial is testing

Evofosfamide in Combination with Zalifrelimab and Balstilimab

Who this might be right for
Metastatic Prostate CancerMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic Cancer
ImmunoGenesis 71
Testing effectiveness (Phase 2)UnknownNCT04926155
What this trial is testing

The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 234
Early research (Phase 1)Study completedNCT05617885
What this trial is testing

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Who this might be right for
Metastatic Prostate CancerNon-metastatic Prostate CancerProstate Cancer
Praful Ravi, MB BCHir, MRCP 9
Next Page